Quaker Chemical experienced a challenging second quarter in 2025, reporting a net loss of $66.6 million, primarily due to an $88.8 million goodwill impairment charge related to its EMEA segment. Despite this, the company saw a 4% increase in net sales to $483.4 million, driven by a 6% contribution from acquisitions and 2% organic sales volume growth. Adjusted EBITDA decreased by approximately 10% year-over-year to $75.5 million, reflecting lower operating margins.
Net sales increased by 4% year-over-year to $483.4 million, primarily due to acquisitions and organic volume growth.
The company reported a net loss of $66.6 million, or $3.78 per diluted share, largely impacted by an $88.8 million goodwill impairment charge.
Non-GAAP net income was $30.0 million, with non-GAAP earnings per diluted share of $1.71.
Adjusted EBITDA was $75.5 million, a decrease of 10% compared to the prior year, with an adjusted EBITDA margin of 15.6%.
Quaker Houghton anticipates tepid economic conditions in the second half of 2025 but expects stronger business performance, aiming to deliver full-year 2025 revenue and earnings in the range of 2024, supported by new business opportunities and cost savings initiatives.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance